CureVac is a global biopharmaceutical company with more than 20 years of experience in developing the mRNA technology for medical purposes.
CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA. Headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr, Steve Pascolo, Florian von der Mulbe, Günther Jung, and... Wikipedia
CEO: Alexander Zehnder (Apr 2023–)
Founders: Ingmar Hoerr, Steve Pascolo, Günther Jung, and more
Headquarters: Tübingen, Germany
CFO: Pierre Kemula
Number of employees: < 700
Date founded: 2000
Show more
Show less
People also ask
Will CureVac stock go up?
The Curevac N.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock.
How many employees does CureVac have?
We built CureVac from life's building blocks
Today, we're more than 1000 passionate people strong, each one committed to using the clinical potential of our proprietary mRNA technology to provide tailored solutions for those with the greatest medical needs.
What does CureVac do?
CureVac (Nasdaq: CVAC) is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes.
Where is CureVac located?
Headquartered in Tübingen, Germany, CureVac also operates sites in the Netherlands, Belgium, Switzerland, and the U.S. Further information can be found at www.curevac.com.
Jul 3, 2024 · Since 2020, GSK and CureVac have worked together to develop mRNA vaccines for infectious diseases. Through this collaboration, GSK and CureVac ...
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
2 days ago · The stock is gaining following a CDC report highlighting a significant increase in acute respiratory illnesses nationwide. Shares of CureVac BV.
This presentation of CureVac N.V. (the “company”) contains statements that constitute “forward-looking statements” as that term is defined in the United States ...